Clovis Oncology, Inc. (CLVS): Up market, down market, its not going to...

Home > Boards > US Listed > Biotechs > Clovis Oncology, Inc. (CLVS)

Followed By	47
Posts	3672
Boards Moderated	0
Alias Born	02/11/2020

Wednesday, April 06, 2022 12:38:57 PM

Re: None

Up market, down market, its not going to matter, sooner more than later, naked shorting criminals are going to get blown up in the worse way.

Recent CLVS News

Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 06/28/2022 12:31:43 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 06/16/2022 08:36:45 PM
Clovis Oncology Highlights Phase 1 Data from Ongoing Clinical Studies of Targeted Radiotherapy Candidate FAP-2286 at SNMMI Annual Meeting • Business Wire • 06/14/2022 06:00:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 06/09/2022 08:48:47 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 06/09/2022 08:46:44 PM
Clovis Oncology (CLVS) Gets a Hold Rating from H.C. Wainwright • TipRanks • 06/06/2022 03:55:10 PM
Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Significantly Improves Progression-Free Survival in Women with Advanced Ovarian Cancer in Primary Efficacy Analyses Regardless of BRCA Mutation and HRD Status • Business Wire • 06/06/2022 12:00:00 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/03/2022 08:17:04 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/03/2022 08:16:50 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/03/2022 08:16:35 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/03/2022 08:16:16 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 06/03/2022 08:16:15 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 06/01/2022 08:16:51 PM
Quarterly Report (10-q) • Edgar (US Regulatory) • 05/05/2022 08:43:52 PM
Clovis Oncology to Present at the BofA Securities 2022 Healthcare Conference • Business Wire • 05/05/2022 12:00:00 PM
Clovis Oncology (CLVS) Receives a Buy from H.C. Wainwright • TipRanks • 05/05/2022 10:17:04 AM
Current Report Filing (8-k) • Edgar (US Regulatory) • 05/04/2022 12:25:39 PM
Clovis Oncology Announces First Quarter 2022 Operating Results and Provides Update on Clinical Development Programs • Business Wire • 05/04/2022 12:00:00 PM
Clovis Oncology Highlights Rubraca® (Rucaparib) and FAP-2286 Data to be Presented at 2022 ASCO Annual Meeting • Business Wire • 04/28/2022 12:00:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 04/27/2022 08:11:06 PM
Proxy Statement (definitive) (def 14a) • Edgar (US Regulatory) • 04/27/2022 08:06:49 PM
Clovis Oncology to Announce First Quarter 2022 Financial Results and Host Webcast Conference Call on May 4 • Business Wire • 04/20/2022 12:00:00 PM
Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 04/11/2022 05:59:39 PM
Clovis Oncology Highlights Presentations on FAP-2286 and Rubraca® (Rucaparib) at the AACR Annual Meeting 2022 • Business Wire • 04/08/2022 12:00:00 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 04/05/2022 08:17:51 PM

More CLVS News

InvestorsHub NewsWire

Pacific Booker Minerals Inc. Announces Annuals Posted and Project Update • PBMLF • Jul 1, 2022 9:30 AM

Maison Luxe Reports Best Ever Annual Revenues of Approximately $ 17.6 mil. for 2022 as Compared to Approximately $ 5.2 mil. for 2021, an Increase of Over 300% and Poised for Rapid Expansion in 2023 • MASN • Jun 30, 2022 9:58 AM

Global Fiber Technologies Secures Second Round of Inventory Financing • GFTX • Jun 30, 2022 9:41 AM

Sugarmade Announces Fully Executed LOI Toward Minority Stake Acquisition of Turnkey Cannabis Cultivation Property • SGMD • Jun 30, 2022 8:30 AM

HPIL(HPIL) Updates Shareholders • HPIL • Jun 30, 2022 8:30 AM

Emerging Markets Report: Cheaper. Simpler. More efficient. Ready to scale. • SPYR • Jun 29, 2022 11:41 AM

Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System • ONPH • Jun 29, 2022 9:23 AM

Infobird Co., Ltd Provides Digital and Intelligent Customer Engagement Solution to Enhance Patient Vaccination Notification Services for a Top-10 Global Pharmaceutical Company's Subsidiary • IFBD • Jun 29, 2022 8:34 AM

Goldshore Resources Drills 78.35m at 1.17 g/t Au and delineates higher grade lenses within Moss lake Deposit • GSHRF • Jun 29, 2022 8:33 AM

PSYC Provides Encouraging Update on its Investment in The Conscious Fund • PSYC • Jun 29, 2022 8:30 AM

Health Advance Inc. (OTC: HADV): Embrace their CBD Innovation Before Everyone Else Does! • HADV • Jun 29, 2022 8:00 AM

Resgreen Group Announces LilBuddy ™ Pilot Testing of Payload Capacity Exceeding Original Expectations • RGGI • Jun 29, 2022 6:00 AM

IGEN's CEO provides mid-year progress update for 2022 • IGEN • Jun 29, 2022 6:00 AM

Splash Beverage Group to Distribute TapouT through Save-A-Lot Grocery Stores in 32 States. • SBEV • Jun 28, 2022 8:23 AM

RYU Apparel Inc. (TSXV: RYU) (OTCQB: RYPPF) Announces Company Achievements and Roadmap For Shareholders with growth in Operations, Rollup Acquisition Strategy, and Disruptive Technology Opportunities • RYPPF • Jun 27, 2022 11:48 AM

Start posting your company's news
Only $200 per official company press release!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
2M
3M
6M
1Y
2Y
3Y
5Y

Detailed Quote

Follow Board

Keyboard Shortcuts

Report TOS Violation